Beyond Warfarin: Unveiling the Dominance of DOACs in DVT Treatment (2024) | ##dvt # #deepveinthrombosis # #anticoagulants # #doacs # #thrombolytics # #pharma # #medicalinnovation # #drugdevelopment # #patientsafety # #healthcare # #bloodclots # #healthtech # #combinationtherapies # #costeffectiveness # #regulatoryaffairs